• La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient …

    SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and …

    Read More
  • 0 0